Accuray Stock

Accuray Net Income 2024

Accuray Net Income

-15.55 M USD

Ticker

ARAY

ISIN

US0043971052

WKN

A0MKWM

In 2024, Accuray's profit amounted to -15.55 M USD, a 67.15% increase from the -9.3 M USD profit recorded in the previous year.

The Accuray Net Income history

YEARNET INCOME (undefined USD)
2027e21.54
2026e13.68
2025e-1.54
2024-15.55
2023-9.3
2022-5.3
2021-6.3
20203.8
2019-16.4
2018-23.9
2017-29.6
2016-25.5
2015-40.2
2014-35.4
2013-103.2
2012-72
2011-26.7
20102.8
20090.6
20085.4
2007-5.6
2006-33.7
2005-25.2

Accuray Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Accuray, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Accuray from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Accuray’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Accuray. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Accuray’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Accuray’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Accuray’s growth potential.

Accuray Revenue, EBIT and net profit per share

DateAccuray RevenueAccuray EBITAccuray Net Income
2027e523.67 M undefined38.56 M undefined21.54 M undefined
2026e503.3 M undefined26.78 M undefined13.68 M undefined
2025e476.22 M undefined9.18 M undefined-1.54 M undefined
2024446.55 M undefined3.1 M undefined-15.55 M undefined
2023447.6 M undefined2.4 M undefined-9.3 M undefined
2022429.9 M undefined8.1 M undefined-5.3 M undefined
2021396.3 M undefined22.2 M undefined-6.3 M undefined
2020382.9 M undefined12.5 M undefined3.8 M undefined
2019418.8 M undefined600,000 undefined-16.4 M undefined
2018404.9 M undefined-3.8 M undefined-23.9 M undefined
2017383.4 M undefined-9.8 M undefined-29.6 M undefined
2016398.8 M undefined-4.9 M undefined-25.5 M undefined
2015379.8 M undefined-19.2 M undefined-40.2 M undefined
2014369.4 M undefined-18.1 M undefined-35.4 M undefined
2013316 M undefined-71.6 M undefined-103.2 M undefined
2012409.2 M undefined-54.3 M undefined-72 M undefined
2011222.3 M undefined-27.8 M undefined-26.7 M undefined
2010221.6 M undefined2.8 M undefined2.8 M undefined
2009233.6 M undefined-2.4 M undefined600,000 undefined
2008210.4 M undefined-900,000 undefined5.4 M undefined
2007140.5 M undefined-8.5 M undefined-5.6 M undefined
200652.9 M undefined-33.5 M undefined-33.7 M undefined
200522.4 M undefined-24.9 M undefined-25.2 M undefined

Accuray stock margins

The Accuray margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Accuray. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Accuray.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Accuray's sales revenue. A higher gross margin percentage indicates that the Accuray retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Accuray's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Accuray's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Accuray's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Accuray. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Accuray's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Accuray Margin History

Accuray Gross marginAccuray Profit marginAccuray EBIT marginAccuray Profit margin
2027e32.05 %7.36 %4.11 %
2026e32.05 %5.32 %2.72 %
2025e32.05 %1.93 %-0.32 %
202432.05 %0.7 %-3.48 %
202334.41 %0.54 %-2.08 %
202237.22 %1.88 %-1.23 %
202140.25 %5.6 %-1.59 %
202039.1 %3.26 %0.99 %
201938.85 %0.14 %-3.92 %
201839.94 %-0.94 %-5.9 %
201736.85 %-2.56 %-7.72 %
201639.79 %-1.23 %-6.39 %
201538.28 %-5.06 %-10.58 %
201438.66 %-4.9 %-9.58 %
201330.89 %-22.66 %-32.66 %
201233.55 %-13.27 %-17.6 %
201148.22 %-12.51 %-12.01 %
201046.93 %1.26 %1.26 %
200949.36 %-1.03 %0.26 %
200850.86 %-0.43 %2.57 %
200756.94 %-6.05 %-3.99 %
200648.02 %-63.33 %-63.71 %
200550.45 %-111.16 %-112.5 %

Accuray Aktienanalyse

What does Accuray do?

Accuray Inc is a company that was founded in 1990 and is headquartered in Sunnyvale, California. It is a global leader in providing precision solutions for the radiation treatment of cancer and other medical conditions. The company aims to develop revolutionary technologies that offer doctors and patients new treatment options for cancer and other diseases. History: Accuray was founded as a start-up company by a group of scientists who believed that cancer treatment was a crucial problem, with a lack of precision and control compromising the effectiveness of treatment. Therefore, they decided to develop a solution focused on precise, non-invasive radiation therapy. Since then, Accuray has continuously developed and introduced innovative technologies to enable better treatment for patients. Business model: Accuray's business model focuses on the development, sale, and service of radiation therapy products and solutions. The company provides global clinical support to ensure that customers receive the best possible application of Accuray technologies. Accuray primarily generates its revenues through the sale of radiation therapy systems and services. The company has over 800 employees worldwide and operates manufacturing locations in the US and China. Products and solutions: Accuray offers a wide range of products and solutions for clinical radiation therapy. These include the TomoTherapy systems, CyberKnife systems, and Radixact systems. The TomoTherapy systems have been specifically designed for precise and patient-specific radiation therapy applications. The technology enables precise dosage of radiation to tumor cells, protecting the surrounding healthy tissues. The CyberKnife system is used for the treatment of tumors that are difficult to access, such as those in the brain or spine. The robotic technology and precise radiation dosage enhance the effectiveness of treatment. With the Radixact system, Accuray offers a system that provides the latest generation of radiation therapy. The system delivers extremely precise dosages to the tumor while maximizing the preservation of surrounding tissues. Divisions: Accuray is divided into three business segments: Oncology Systems, Radiation Therapy Services, and Research Solutions. - Oncology Systems: Accuray offers the aforementioned TomoTherapy, CyberKnife, and Radixact systems, providing customers with the latest technology to treat various types of cancer. - Radiation Therapy Services: Accuray also provides a wide range of service and support offerings for its customers. These services include training, maintenance, technician support, and customer support. - Research Solutions: Accuray's research division provides academic institutions and research laboratories with access to a variety of technologies and solutions for radiation therapy and cancer research. Conclusion: Accuray has tirelessly worked to develop innovative technologies for radiation therapy, enabling better treatment and quality of life for patients. The company has made significant progress in recent years and now offers a wide range of products and solutions to its customers. Accuray has established itself as a global leader in radiation therapy and continues its success story with continuous research and innovation. Answer: Accuray Inc is a company that specializes in providing precision solutions for radiation treatment of cancer and other medical conditions. It was founded in 1990 and is headquartered in Sunnyvale, California. The company aims to develop innovative technologies that offer patients and doctors new treatment possibilities. Accuray has three divisions: Oncology Systems, Radiation Therapy Services, and Research Solutions. Their products include TomoTherapy, CyberKnife, and Radixact systems. Accuray is a leading global provider of radiation therapy solutions and continues to make advancements in research and innovation. Accuray ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Accuray's Profit Margins

The profit margins of Accuray represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Accuray's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Accuray's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Accuray's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Accuray’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Accuray stock

How much profit has Accuray made this year?

Accuray has made -15.55 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 67.15% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Accuray publish its earnings?

Accuray publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Accuray?

The profits of Accuray are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Accuray?

You can learn more about the earnings of Accuray by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Accuray pay?

Over the past 12 months, Accuray paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Accuray is expected to pay a dividend of 0 USD.

What is the dividend yield of Accuray?

The current dividend yield of Accuray is .

When does Accuray pay dividends?

Accuray pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Accuray?

Accuray paid dividends every year for the past 0 years.

What is the dividend of Accuray?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Accuray located?

Accuray is assigned to the 'Health' sector.

Wann musste ich die Aktien von Accuray kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Accuray from 12/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.

When did Accuray pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of Accuray in the year 2023?

In the year 2023, Accuray distributed 0 USD as dividends.

In which currency does Accuray pay out the dividend?

The dividends of Accuray are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Accuray stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Accuray

Our stock analysis for Accuray Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Accuray Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.